Children with phenylketonuria treated early: basic audiological and electrophysiological evaluation

Patrícia Cotta Mancini1, John D Durrant, Ana Lúcia Pimenta Starling

  • 1Department of Speech Pathology and Audiology, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. pmancini@medicina.ufmg.br

Ear and Hearing
|October 6, 2012
PubMed

Insights

Children with phenylketonuria (PKU) may experience auditory pathway effects, even with early treatment. Auditory processing assessments are recommended for monitoring these potential impacts.

Area of Science:

  • Neuroscience
  • Audiology
  • Genetics

Background:

  • Phenylketonuria (PKU) is a genetic disorder often associated with cognitive deficits, including executive function and attention impairments.
  • These deficits are presumed to stem from deficient neurotransmitter synthesis, even with early diagnosis and treatment.
  • The impact of PKU on auditory pathways, particularly in early-treated individuals, requires further investigation.

Purpose of the Study:

  • To examine the peripheral and central auditory pathways in children with early-treated PKU.
  • To compare auditory pathway function between children with adequate versus inadequate dietary control for PKU.
  • To compare auditory function in children with PKU to age-matched controls without PKU.

Main Methods:

  • Utilized basic audiological and electrophysiological evaluations, including pure-tone and speech audiometry, immittance testing, and auditory brainstem and middle latency responses.
  • Compared 25 children with early-treated PKU (subdivided by diet adequacy) against 35 age-matched controls.
  • Analyzed demographic and audiological data using analysis of variance with repeated measures.

Main Results:

  • Audiometric evaluations were largely within normal limits, with one exception of mild conductive hearing loss in the inadequate diet group.
  • Children with inadequate diets (Group B) showed poorer speech discrimination and higher 4000 Hz stapedial reflex thresholds.
  • Auditory brainstem responses indicated longer latencies in Group B, and both PKU groups exhibited longer interpeak interval I-V compared to controls.

Conclusions:

  • Early-treated PKU may affect the pontine auditory pathway, independent of dietary adherence.
  • Observed differences, though small, suggest a need for auditory processing assessments in children with PKU.
  • Monitoring auditory function can help evaluate the functional implications of PKU on auditory pathways.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...